26/08/05 Healthcare Associated Infection - Surveillance of Clostridium Difficile Associated Disease (CDAD) and Glycopeptide-resistant enterococci (GRE)

Surveillance of Clostridium difficile associated disease (CDAD) and Surveillance of glycopeptide-resistant enterococci (GRE) are both included in the mandatory healthcare associated infection surveillance system for acute Trusts in England,  CDAD since January 2004 and GRE since September 2003. This scheme is co-ordinated by the Health Protection Agency (HPA) on behalf of the Department of Health. CDAD Data is collected quarterly from each of the 169 acute NHS Trusts in England that treat patients aged 65 years and over (children’s Trusts are excluded). GRE Data is collected quarterly from each of the 173 acute NHS Trusts in England .

Further information on both of these is available from the Health Protection Agency Healthcare Associated Infection web site.

(DH GRE press release, CDAD press release, BBC news story)